• Heliad co-led sci2sci’s EUR 1.2 million pre-seed round alongside IBB Ventures, with Robin Capital, Superangels participating.
• sci2sci is a Berlin startup building a neurosymbolic memory and verification layer to make AI outputs auditable in regulated industries.
• Funding targets engineering hires, faster rollout of Integrity Cortex, deployments of VectorCat across biopharma workflows.
• Product focus is traceable, deterministic verification of claims with audit trails designed for regulatory submissions and compliance records.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heliad AG published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.